{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:08Z","timestamp":1772165768701,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical and Health Talent Training Program","award":["023YZ09"],"award-info":[{"award-number":["023YZ09"]}]},{"name":"Medical and Health Talent Training Program","award":["023YZ09"],"award-info":[{"award-number":["023YZ09"]}]},{"name":"Medical and Health Talent Training Program","award":["023YZ09"],"award-info":[{"award-number":["023YZ09"]}]},{"name":"Medical and Health Talent Training Program","award":["023YZ09"],"award-info":[{"award-number":["023YZ09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15045-4","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T08:34:06Z","timestamp":1761208446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The value of second-generation gene sequencing in lung cancer immunotherapy with concurrent infections"],"prefix":"10.1186","volume":"25","author":[{"given":"Yaqin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiangqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"issue":"5","key":"15045_CR1","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s10147-019-01548-1","volume":"25","author":"H Hayashi","year":"2020","unstructured":"Hayashi H, Nakagawa K. Combination therapy with PD-1 or PD-L1 inhibitors for cancer. Int J Clin Oncol. 2020;25(5):818\u201330.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"15045_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cac2.12627","volume":"45","author":"X Diao","year":"2025","unstructured":"Diao X, Guo C, Jin Y, et al. Cancer situation in China: an analysis based on the global epidemiological data released in 2024. Cancer Commun. 2025;45(2):178\u201397.","journal-title":"Cancer Commun"},{"key":"15045_CR3","doi-asserted-by":"publisher","DOI":"10.2196\/43651","volume":"9","author":"G Luo","year":"2023","unstructured":"Luo G, Zhang Y, Etxeberria J, et al. Projections of lung cancer incidence by 2035 in 40 countries worldwide: population-based study. JMIR Public Health Surveill. 2023;9:e43651.","journal-title":"JMIR Public Health Surveill"},{"issue":"7","key":"15045_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.annonc.2021.04.008","volume":"32","author":"D Rodriguez-Abreu","year":"2021","unstructured":"Rodriguez-Abreu D, Powell SF, Hochmair MJ, et al. Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189. Ann Oncol. 2021;32(7):881\u201395.","journal-title":"Ann Oncol"},{"issue":"5","key":"15045_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S2213-2600(19)30084-0","volume":"7","author":"M Reck","year":"2019","unstructured":"Reck M, Mok TSK, Nishio M, et al. Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial. Lancet Respir Med. 2019;7(5):387\u2013401.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"15045_CR6","first-page":"86","volume":"70","author":"LB Kennedy","year":"2020","unstructured":"Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70(2):86\u2013104.","journal-title":"CA Cancer J Clin"},{"key":"15045_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1338307","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang J, Gan X, et al. Application of plasma metagenomic next-generation sequencing improves prognosis in hematology patients with neutropenia or hematopoietic stem cell transplantation for infection. Front Cell Infect Microbiol. 2024;14:1338307.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"15045_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.mcna.2018.12.008","volume":"103","author":"CW Lanks","year":"2019","unstructured":"Lanks CW, Musani AI, Hsia DW. Community-acquired pneumonia and hospital-acquired pneumonia. Med Clin North Am. 2019;103(3):487\u2013501.","journal-title":"Med Clin North Am"},{"issue":"4","key":"15045_CR9","first-page":"322","volume":"46","author":"Consensus of clinical","year":"2023","unstructured":"Consensus of clinical. Pathways of metagenomic next-generation sequencing test in diagnosis of lower respiratory tract infections in China. Zhonghua Jie He He Hu Xi Za Zhi. 2023;46(4):322\u201335.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"15045_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijid.2020.11.166","volume":"103","author":"S Geng","year":"2021","unstructured":"Geng S, Mei Q, Fang X, et al. Metagenomic next-generation sequencing technology for detection of pathogens in blood of critically ill patients. Int J Infect Dis. 2021;103:81\u20137.","journal-title":"Int J Infect Dis"},{"key":"15045_CR11","doi-asserted-by":"publisher","DOI":"10.2196\/49968","volume":"9","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Rumgay H, Li M, et al. Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profiling. JMIR Public Health Surveill. 2023;9:e49968.","journal-title":"JMIR Public Health Surveill"},{"issue":"6","key":"15045_CR12","first-page":"1024","volume":"33","author":"YC Ma","year":"2025","unstructured":"Ma YC, Xie YJ, Zhou YW, et al. Research progress and prospects on immunotherapy of extensive-stage small cell lung cancer. Mod Oncol. 2025;33(6):1024\u201333.","journal-title":"Mod Oncol"},{"issue":"8","key":"15045_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/14712598.2020.1762561","volume":"20","author":"B Tang","year":"2020","unstructured":"Tang B, Chi Z, Guo J. Toripalimab for the treatment of melanoma. Expert Opin Biol Ther. 2020;20(8):863\u20139.","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"15045_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin X, Kang K, Chen P, et al. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer. 2024;23(1):108.","journal-title":"Mol Cancer"},{"issue":"9","key":"15045_CR15","first-page":"772","volume":"23","author":"Q Qin","year":"2020","unstructured":"Qin Q, Wang J, Wang H. Immune-related adverse events induced by ICIs in advanced NSCLC: A Meta-analysis and systematic Review. Zhongguo Fei Ai Za Zhi. 2020;23(9):772\u201391.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"15045_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.541092","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Feng W, Ye K, et al. Application of metagenomic next-generation sequencing in the diagnosis of pulmonary infectious pathogens from bronchoalveolar lavage samples. Front Cell Infect Microbiol. 2021;11:541092.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"15045_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07381-8","volume":"22","author":"P Lin","year":"2022","unstructured":"Lin P, Chen Y, Su S, et al. Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients. BMC Infect Dis. 2022;22(1):416.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"15045_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13743-7","volume":"25","author":"X Wang","year":"2025","unstructured":"Wang X, Wu Y, Hu W, et al. Incidence and risk factors of serious infections occurred in patients with lung cancer following immune checkpoint blockade therapy. BMC Cancer. 2025;25(1):307.","journal-title":"BMC Cancer"},{"issue":"18","key":"15045_CR19","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1200\/JCO.2014.60.0379","volume":"33","author":"JS Weber","year":"2015","unstructured":"Weber JS, Yang JC, Atkins MB, et al. Toxicities of immunotherapy for the Practitioner. J Clin Oncol. 2015;33(18):2092\u20139.","journal-title":"J Clin Oncol."},{"key":"15045_CR20","unstructured":"Salerno F, Guislain A, Canivet CM et al. PD-1 Blockade and viral infection: A new frontier for immune checkpoint Inhibitors. Front Immunol. 2020;11:1047."},{"issue":"11","key":"15045_CR21","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/cid\/ciw539","volume":"63","author":"M Del Castillo","year":"2016","unstructured":"Del Castillo M, Romero FA, Arg\u00fcello E, et al. The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma. Clin Infect Dis. 2016;63(11):1490\u20133.","journal-title":"Clin Infect Dis"},{"key":"15045_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696403","volume":"12","author":"W Tang","year":"2021","unstructured":"Tang W, Zhang Y, Luo C, et al. Clinical application of metagenomic next-generation sequencing for suspected infections in patients with primary immunodeficiency disease. Front Immunol. 2021;12:696403.","journal-title":"Front Immunol"},{"issue":"7","key":"15045_CR23","first-page":"998","volume":"22","author":"N Fan","year":"2025","unstructured":"Fan N, Jiang DR, Wang Y. Progress in the treatment of PD-1\/PD-L1 inhibitors in lung cancer complicated with pulmonary tuberculosis disease. Lab Med Clin. 2025;22(7):998\u20131002.","journal-title":"Lab Med Clin"},{"issue":"3","key":"15045_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cmi.2017.12.003","volume":"24","author":"H Picchi","year":"2018","unstructured":"Picchi H, Mateus C, Chouaid C, et al. Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment. Clin Microbiol Infect. 2018;24(3):216\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"15045_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01230-7","volume":"20","author":"D Giller","year":"2020","unstructured":"Giller D, Giller B, Scherbakova G, et al. Extensive tracheal resection in lung cancer and tuberculosis: a case report. BMC Pulm Med. 2020;20(1):197.","journal-title":"BMC Pulm Med"},{"key":"15045_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00157-2017","author":"CC Dobler","year":"2017","unstructured":"Dobler CC, Cheung K, Nguyen J, et al. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.00157-2017.","journal-title":"Eur Respir J"},{"key":"15045_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat2702","author":"DL Barber","year":"2019","unstructured":"Barber DL, Sakai S, Kudchadkar RR, et al. Tuberculosis following PD-1 blockade for cancer immunotherapy. Sci Transl Med. 2019. https:\/\/doi.org\/10.1126\/scitranslmed.aat2702.","journal-title":"Sci Transl Med"},{"issue":"1","key":"15045_CR28","first-page":"69","volume":"82","author":"T Shimizu","year":"2020","unstructured":"Shimizu T, Okachi S, Imai N, et al. Risk factors for pulmonary infection after diagnostic bronchoscopy in patients with lung cancer. Nagoya J Med Sci. 2020;82(1):69\u201377.","journal-title":"Nagoya J Med Sci"},{"key":"15045_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.rmed.2018.11.021","volume":"146","author":"K Fujita","year":"2019","unstructured":"Fujita K, Kim YH, Kanai O, et al. Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy. Respir Med. 2019;146:66\u201370.","journal-title":"Respir Med"},{"issue":"10","key":"15045_CR30","first-page":"666","volume":"22","author":"WY Lu","year":"2019","unstructured":"Lu WY, Zhang L, Li Y, et al. Recommendation of diagnosis and management for the infection related to immune checkpoint inhibitors. Chin Lung Cancer. 2019;22(10):666\u201370.","journal-title":"Chin Lung Cancer"},{"issue":"3","key":"15045_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/thoraxjnl-2021-217260","volume":"77","author":"T Morelli","year":"2022","unstructured":"Morelli T, Fujita K, Redelman-Sidi G, et al. Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy. Thorax. 2022;77(3):304\u201311.","journal-title":"Thorax"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15045-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T08:34:09Z","timestamp":1761208449000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15045-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15045"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15045-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6906725\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study achieved formal approval from the Ethics Committee of The First Affiliated Hospital of Yangtze University (ethical number: YJ202427).This study was retrospective, and the Ethics Committee of The First Affiliated Hospital of Yangtze Universitl waived the requirement of extra patient consent statements because written informed consent was obtained from all patients admitted to allow their medical records to be used in clinical observational studies.All identifying information was removed to protect patient confidentiality according to the requirement of the Ethics Committee of The First Affiliated Hospital of Yangtze University. This study was designed and conducted in accord ance with the Declaration of Helsinki and local institutional standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1636"}}